Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer
暂无分享,去创建一个
M. Hendrix | E. Perez | E. Thompson | E. Seftor | L. Strizzi | W. Lingle | N. Margaryan | C. Andorfer | Katharine M. Hardy | X. Geiger | Beiyun Chen | D. Hillman | E. Thompson | Edith A. Perez | David W. Hillman
[1] Mariano J. Alvarez,et al. Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling , 2011, Development.
[2] M. Hendrix,et al. Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells , 2011, The Prostate.
[3] Jorge S. Reis-Filho,et al. Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement , 2011, Journal of the National Cancer Institute.
[4] M. Hendrix,et al. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. , 2010, Cancer research.
[5] V. Band,et al. Histological, molecular and functional subtypes of breast cancers , 2010, Cancer biology & therapy.
[6] A. Thompson,et al. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS) , 2010, Breast Cancer Research.
[7] P. Talbot,et al. Comparison of the toxicity of smoke from conventional and harm reduction cigarettes using human embryonic stem cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[8] E. Perez,et al. Treatment options for patients with triple-negative breast cancer , 2010, Journal of hematology & oncology.
[9] O. Ashur-Fabian,et al. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology. , 2010, Current opinion in endocrinology, diabetes, and obesity.
[10] D. Fullen,et al. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions , 2010, Modern Pathology.
[11] B. Vonderhaar,et al. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. , 2010, Cancer research.
[12] Y-C Lee,et al. Nodal promotes growth and invasion in human gliomas , 2010, Oncogene.
[13] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.
[14] M. Lackmann,et al. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer , 2009, Reproductive biology and endocrinology : RB&E.
[15] M. Wicha. Targeting breast cancer stem cells. , 2009, Breast.
[16] M. Hendrix,et al. Development and cancer: at the crossroads of Nodal and Notch signaling. , 2009, Cancer research.
[17] D. Constam. Running the gauntlet: an overview of the modalities of travel employed by the putative morphogen Nodal. , 2009, Current opinion in genetics & development.
[18] M. Hendrix,et al. Potential for Cripto-1 in defining stem cell-like characteristics in human malignant melanoma , 2008, Cell cycle.
[19] Ian O Ellis,et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. D. de Vries,et al. Prognostic versus predictive value of biomarkers in oncology. , 2008, European journal of cancer.
[21] M. Hendrix,et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells , 2008, Proceedings of the National Academy of Sciences.
[22] M. J. van de Vijver,et al. Immunohistochemical categorisation of ductal carcinoma in situ of the breast , 2007, British Journal of Cancer.
[23] R. Bast,et al. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. , 2007, Journal of oncology practice.
[24] M. Shen. Nodal signaling: developmental roles and regulation , 2007, Development.
[25] D. Constam,et al. The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. , 2006, Developmental cell.
[26] G. D'aiuto,et al. Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer , 2006, Clinical Cancer Research.
[27] M. Hendrix,et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness , 2006, Nature Medicine.
[28] David Salomon,et al. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis , 2005, Oncogene.
[29] G. Chetrite,et al. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[30] R. Pedersen,et al. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. , 2004, Developmental biology.
[31] G. Baldwin,et al. Gastrins, cholecystokinins and gastrointestinal cancer. , 2004, Biochimica et biophysica acta.
[32] A. Schier. Nodal signaling in vertebrate development. , 2003, Annual review of cell and developmental biology.
[33] B. Moon,et al. Secretory carcinoma of the breast , 2003, Journal of clinical ultrasound : JCU.
[34] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Kaaks,et al. Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .
[36] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[37] Shousha,et al. Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins , 1999, Histopathology.
[38] G. Chetrite,et al. Progestins and breast cancer 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco, 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[39] Raj Kumar,et al. Steroid hormone receptors in cancer development: a target for cancer therapeutics. , 2011, Cancer letters.
[40] M. Hendrix,et al. Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. , 2009, Expert review of dermatology.
[41] M. Hendrix,et al. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. , 2008, Breast disease.